Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxegol in Cancer Patients with Opioid-Induced Constipation
NCT02839889Phase 4Terminated
- Sponsor
- Four Seasons
- Start
- Sep 2016
- Primary completion
- Jan 2018
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of naloxegol in opioid-induced constipation (OIC), sponsored by Four Seasons. Started Sep 2016; status: terminated.
02
Drugs
naloxegol
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT02839889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02839889.